{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:40:28Z","timestamp":1777887628187,"version":"3.51.4"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Current prognostic models for cerebral venous sinus thrombosis (CVST) inadequately predict long-term cognitive and functional outcomes, focusing primarily on survival. We aimed to develop and validate a simple, acute-phase clinical phenotyping system to stratify the risk of these disabling sequelae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cohort study, consecutive adult CVST patients between 2014 and 2024 were included. Patients were classified into three acute-phase phenotypes: Benign Intracranial Hypertension, Focal Brain Injury, and Diffuse Brain Injury. Long-term outcomes (cognitive impairment, depressive symptoms, return to work) were assessed at a median of 1\u202fyear post-onset via telephone interview. Multivariable logistic regression analyses adjusted for key confounders were used to determine independent associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 110 patients, the prevalence of the Benign, Focal, and Diffuse Brain Injury phenotypes was 33.6% (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f37), 38.2% (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f42), and 28.2% (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f31), respectively. A significant gradient of worsening outcomes was observed across the three phenotypes based on the dominant clinical syndrome of isolated intracranial hypertension, focal, or diffuse brain injury. The prevalence of cognitive impairment (MoCA&amp;lt;26) was 27.0, 59.5, and 90.3% (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), and the rate of return to work was 89.2, 66.7, and 32.3% (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.002), respectively. After adjustment, both the Focal (aOR\u202f=\u202f3.26, 95% CI: 1.18\u20139.01) and Diffuse Brain Injury (aOR\u202f=\u202f9.21, 95% CI: 2.84\u201329.87) phenotypes were independent predictors of cognitive impairment versus the Benign phenotype. The Diffuse Brain Injury phenotype was also independently associated with depressive symptoms (aOR\u202f=\u202f4.85, 95% CI: 1.67\u201314.09) and an 85% reduced odds of returning to work (aOR\u202f=\u202f0.15, 95% CI: 0.05\u20130.43).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A simple, bedside-accessible clinical phenotyping system effectively stratifies long-term risk in CVST patients. The Diffuse Brain Injury phenotype warrants early, multidisciplinary intervention to mitigate its multifaceted poor prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1754770","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:19:20Z","timestamp":1777609160000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute-phase clinical phenotyping stratifies long-term cognitive and functional outcomes in cerebral venous sinus thrombosis"],"prefix":"10.3389","volume":"17","author":[{"given":"Wentao","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Ganzhou Hospital-Nanfang Hospital, Southern Medical University","place":["Ganzhou, China"]},{"name":"Department of Neurosurgery, Ganzhou People\u2019s Hospital","place":["Ganzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ganzhou Hospital-Nanfang Hospital, Southern Medical University","place":["Ganzhou, China"]},{"name":"Department of Hematology, Ganzhou People\u2019s Hospital","place":["Ganzhou, China"]},{"name":"Jiangxi Health Commission Key Laboratory of Leukemia, the Affiliated Ganzhou Hospital, Jiangxi Medical College","place":["Ganzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.nec.2024.02.006","article-title":"Cerebral venous sinus thrombosis","volume":"35","author":"Nguyen","year":"2024","journal-title":"Neurosurg Clin N Am"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4103\/aian.AIAN_191_19","article-title":"Depression and quality of life after cerebral venous sinus thrombosis","volume":"23","author":"Saroja","year":"2020","journal-title":"Ann Indian Acad Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"jnis-2025-023392","DOI":"10.1136\/jnis-2025-023392","article-title":"Cognitive impairment in cerebral venous congestion: the need for improved assessment tools - a literature review","volume":"18","author":"Hui","year":"2025","journal-title":"J Neurointerv Surg"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00415-015-7996-9","article-title":"Long-term outcome after cerebral venous thrombosis: analysis of functional and vocational outcome, residual symptoms, and adverse events in 161 patients","volume":"263","author":"Hiltunen","year":"2016","journal-title":"J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3389\/fneur.2018.00882","article-title":"A practical score for prediction of outcome after cerebral venous thrombosis","volume":"9","author":"Barboza","year":"2018","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.5551\/jat.64043","article-title":"The novel biomarkers-based HALP (hemoglobin, albumin, lymphocyte and platelet)-prognostic model for acute and subacute patients with cerebral venous sinus thrombosis: a retrospective cohort study","volume":"30","author":"Li","year":"2023","journal-title":"J Atheroscler Thromb"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/svn-2020-000362","article-title":"Prognostic value of systemic immune-inflammation index in acute\/subacute patients with cerebral venous sinus thrombosis","volume":"5","author":"Li","year":"2020","journal-title":"Stroke Vasc Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/j.1468-1331.2010.03011.x","article-title":"EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients","volume":"17","author":"Einh\u00e4upl","year":"2010","journal-title":"Eur J Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.dadm.2015.05.002","article-title":"Concordance of the Montreal cognitive assessment with standard neuropsychological measures","volume":"1","author":"Vogel","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.comppsych.2016.07.011","article-title":"Diagnostic validity of the patient health Questionnaire-2 (PHQ-2) among Ethiopian adults","volume":"70","author":"Gelaye","year":"2016","journal-title":"Compr Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12883-025-04059-x","article-title":"Key prognostic risk factors linked to poor functional outcomes in cerebral venous sinus thrombosis: a systematic review and meta-analysis","volume":"25","author":"Lin","year":"2025","journal-title":"BMC Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1111\/ene.14727","article-title":"Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis","volume":"28","author":"Baldini","year":"2021","journal-title":"Eur J Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/brain\/awq347","article-title":"White matter damage and cognitive impairment after traumatic brain injury","volume":"134","author":"Kinnunen","year":"2011","journal-title":"Brain"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jmri.25548","article-title":"Small world properties changes in mild traumatic brain injury","volume":"46","author":"Zhou","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1089\/neu.2024.0566","article-title":"Inflammatory, white matter, and neurodegenerative mechanisms in fluid ability decrements in chronic mild-to-moderate traumatic brain injury","volume":"42","author":"Penhale","year":"2025","journal-title":"J Neurotrauma"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"27386","DOI":"10.1038\/s41598-024-79052-4","article-title":"Aberrant dynamic functional network connectivity in patients with diffuse axonal injury","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1089\/neu.2023.0020","article-title":"Cognitive outcome after complicated mild traumatic brain injury: a literature review and Meta-analysis","volume":"40","author":"Hacker","year":"2023","journal-title":"J Neurotrauma"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"110457","DOI":"10.1016\/j.mehy.2020.110457","article-title":"Venous dysfunction plays a critical role in \"normal\" white matter disease of aging","volume":"146","author":"Kapadia","year":"2021","journal-title":"Med Hypotheses"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s11357-021-00361-x","article-title":"Neurovascular-glymphatic dysfunction and white matter lesions","volume":"43","author":"Sabayan","year":"2021","journal-title":"Geroscience"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/aian.aian_792_23","article-title":"Clinicoradiological features and long-term cognitive and functional outcome in patients with deep cerebral venous thrombosis","volume":"27","author":"Patwardhan","year":"2024","journal-title":"Ann Indian Acad Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/life13020334","article-title":"Challenges in cerebral venous thrombosis management-case reports and short literature review","volume":"13","author":"Ple\u0219a","year":"2023","journal-title":"Life"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/jnnp-2017-317548","article-title":"Co-occurrence of depressive symptoms and executive dysfunction after stroke: associations with brain pathology and prognosis","volume":"89","author":"Douven","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","article-title":"Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and Dural sinus thrombosis (ISCVT)","volume":"35","author":"Ferro","year":"2004","journal-title":"Stroke"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e898","DOI":"10.1212\/WNL.0000000000009998","article-title":"Prediction of cerebral venous thrombosis with a new clinical score and D-dimer levels","volume":"95","author":"Heldner","year":"2020","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1161\/STR.0000000000000456","article-title":"Diagnosis and Management of Cerebral Venous Thrombosis: a scientific statement from the American Heart Association","volume":"55","author":"Saposnik","year":"2024","journal-title":"Stroke"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/ene.13381","article-title":"European stroke organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European academy of neurology","volume":"24","author":"Ferro","year":"2017","journal-title":"Eur J Neurol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e1716","DOI":"10.1212\/WNL.0000000000010576","article-title":"Late seizures in cerebral venous thrombosis","volume":"95","author":"S\u00e1nchez van Kammen","year":"2020","journal-title":"Neurology"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1754770\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:19:20Z","timestamp":1777609160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1754770\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":27,"alternative-id":["10.3389\/fneur.2026.1754770"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1754770","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"1754770"}}